Disc Medicine Inc.
57.91
-0.83 (-1.41%)
At close: Jan 14, 2025, 3:59 PM
57.83
-0.14%
After-hours Jan 14, 2025, 04:00 PM EST
undefined%
Bid 45.87
Market Cap 1.72B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -3.95
PE Ratio (ttm) -14.66
Forward PE n/a
Analyst Buy
Ask 59.8
Volume 268,432
Avg. Volume (20D) 320,200
Open 59.20
Previous Close 58.74
Day's Range 57.46 - 60.42
52-Week Range 25.60 - 77.60
Beta undefined

About IRON

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, M...

Industry Biotechnology
Sector Healthcare
IPO Date Aug 12, 2020
Employees 82
Stock Exchange NASDAQ
Ticker Symbol IRON

Analyst Forecast

According to 10 analyst ratings, the average rating for IRON stock is "Buy." The 12-month stock price forecast is $72.5, which is an increase of 25.19% from the latest price.

Buy 90.00%
Hold 10.00%
Sell 0.00%
Stock Forecasts
2 months ago · Source
+11.21%
Disk Medicine shares are trading higher. HC Wainwr... Unlock content with Pro Subscription
2 months ago · Source
+23.59%
Disc Medicine shares are trading higher after the company announced the end of its Phase 2 Bitopertin In Erythropoietic Protoporphyria meeting with the FDA. The company is aligned with the FDA across all proposed study parameters and has a clear development path to registration.